Sergio Fazio
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 37
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health 82
-
- Lipid metabolism and disorders 10
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 14
- Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases 12
-
- Pharmaceutical Economics and Policy 17
- Health Systems, Economic Evaluations, Quality of Life 12
-
- Adipokines, Inflammation, and Metabolic Diseases 11
- Co-authors
- Michael D. ShapiroHagai TavoriMacRae F. LintonSalim S. ViraniPratik B. SandesaraRobert S. RosensonM. John ChapmanMarc S. Sabatine
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Sergio Fazio
136 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Endocrinology, Diabetes and Metabolism 2.3k
- Surgery 4.6k
- Cardiology and Cardiovascular Medicine 1.9k
- Cancer Research 1.2k
- Immunology 1.4k
Countries citing papers authored by Sergio Fazio
This map shows the geographic impact of Sergio Fazio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Fazio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Fazio more than expected).
Fields of papers citing papers by Sergio Fazio
This network shows the impact of papers produced by Sergio Fazio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Fazio. The network helps show where Sergio Fazio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sergio Fazio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 15 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 31 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 27 | |
| 10 | 2022 | 26 | |
| 11 | 2020 | 40 | |
| 12 | 2020 | 12 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 23 | |
| 15 | 2018 | 30 | |
| 16 | 2017 | 15 | |
| 17 | Abstract P044: Alcohol Consumption, Statin Use and Risk of All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort | 2015 | 1 |
| 18 | 2014 | 49 | |
| 19 | 2010 | 173 | |
| 20 | 1994 | 102 |
About Sergio Fazio
Sergio Fazio is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine, having authored 143 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (82 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (37 papers), Pharmaceutical Economics and Policy (17 papers), Cancer, Lipids, and Metabolism (14 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Lipid metabolism and disorders (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Surgery (4.6k citations) and Cardiology and Cardiovascular Medicine (1.9k citations). Sergio Fazio has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Michael D. Shapiro, Hagai Tavori, MacRae F. Linton, Salim S. Virani, Pratik B. Sandesara, Robert S. Rosenson, M. John Chapman, Marc S. Sabatine, Robert P. Giugliano and Alberico L. Catapano. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.